This report provides a comprehensive analysis of the global digital therapeutics for neurological disorders market, projecting steady growth through 2033. It examines key product categories, including software therapeutics and wearable devices, across diverse disease types such as neurodegenerative, mental health, and sleep disorders. By evaluating competitive landscapes and regional dynamics, the research offers actionable intelligence on market drivers and technological trends. This study serves as a vital resource for stakeholders navigating the evolving landscape of data-driven neurological care.

Market Overview

The Digital Therapeutics for Neurological Disorders market reached US$ 267.43 million in 2025 and is expected to reach US$ 504.36 million by 2033, growing at a CAGR of 8.30% during the forecast period 2026-2033.

This market emerges as a key focus in DataM Intelligence's latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Digital Therapeutics for Neurological Disorders market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

Market Segmentation

By Product Type

• Software Therapeutics
• Wearable Devices

By Disease Type

• Neurodegenerative Disorders:
• Alzheimer’s Disease
• Parkinson’s Disease
• Multiple Sclerosis
• Huntington’s Disease
• Others
• Mental Health Disorders:
• Depression
• Anxiety
• Post-Traumatic Stress Disorder
• Bipolar Disorder
• Obsessive-Compulsive Disorder (OCD)
• Stroke & Cerebrovascular Disorders
• Sleep Disorders:
• Insomnia
• Sleep Apnea
• Cognitive Disorders
• Others

By End-User

• Hospitals
• Specialty Clinics
• Neuro-Rehabilitation Centers
• Homecare Settings
• Others

Regional Analysis

• North America: U.S., Canada, Mexico
• Europe: U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe
• Asia-Pacific: India, Japan, China, South Korea, Australia, Indonesia and Rest of Asia Pacific
• South America: Colombia, Brazil, Argentina, Rest of South America
• Middle East & Africa: Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa

Report Scope and Coverage

This report includes the following analyses:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process

Both primary and secondary data sources have been used in the global Digital Therapeutics for Neurological Disorders Market research report. During the research process, a wide range of industry-affecting factors are examined, including:

• Governmental regulations
• Market conditions
• Competitive levels
• Historical data
• Market situation
• Technological advancements
• Upcoming developments in related businesses
• Market volatility, prospects, potential barriers, and challenges.

• 1 Market Introduction and Scope

  • 1.1 Objectives of the Report

  • 1.2 Report Coverage & Definitions

  • 1.3 Report Scope

• 2 Executive Insights and Key Takeaways

• 3 Market Highlights and Strategic Takeaways

  • 3.1 Key Trends and Future Projections

• 4 Snippet by Product Type

  • 4.1 Snippet by Disease Type

  • 4.2 Snippet by End-User

  • 4.3 Snippet by Region

• 5 Dynamics

  • 5.1 Impacting Factors

    • 5.1.1 Drivers

      • 5.1.1.1 Shift Towards Home-Based Care & Remote Patient Monitoring
      • 5.1.1.2 Rising Prevalence of Neurological Disorders
      • 5.1.1.3 XX

    • 5.1.2 Restraints

      • 5.1.2.1 Data Privacy & Cybersecurity Concerns
      • 5.1.2.2 Patient Adherence & Engagement Challenges
      • 5.1.2.3 XX

    • 5.1.3 Opportunity

      • 5.1.3.1 Rising Technological Advancements
      • 5.1.3.2 XX

    • 5.1.4 Impact Analysis

• 6 Strategic Insights and Industry Outlook

  • 6.1 Market Leaders and Pioneers

    • 6.1.1 Emerging Pioneers and Prominent Players

    • 6.1.2 Established Leaders with Largest Selling Brand

    • 6.1.3 Market Leaders with Established Product

  • 6.2 CXO Perspectives

  • 6.3 Latest Developments and Breakthroughs

  • 6.4 Case Studies/Ongoing Research

  • 6.5 Regulatory and Reimbursement Landscape

    • 6.5.1 North America

    • 6.5.2 Europe

    • 6.5.3 Asia Pacific

    • 6.5.4 Latin America

    • 6.5.5 Middle East & Africa

  • 6.6 Porter’s Five Force Analysis

  • 6.7 Supply Chain Analysis

  • 6.8 Patent Analysis

  • 6.9 SWOT Analysis

  • 6.10 Unmet Needs and Gaps

  • 6.11 Recommended Strategies for Market Entry and Expansion

  • 6.12 Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts

  • 6.13 Pricing Analysis and Price Dynamics

  • 6.14 Key Opinion Leaders

• 7 Digital Therapeutics for Neurological Disorders Market, By Product Type

  • 7.1 Introduction

    • 7.1.1 Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type

    • 7.1.2 Market Attractiveness Index, By Product Type

  • 7.2 Software Therapeutics*

    • 7.2.1 Introduction

    • 7.2.2 Market Size Analysis and Y-o-Y Growth Analysis (%)

  • 7.3 Wearable Devices

• 8 Digital Therapeutics for Neurological Disorders Market, By Disease Type

  • 8.1 Introduction

    • 8.1.1 Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type

    • 8.1.2 Market Attractiveness Index, By Disease Type

  • 8.2 Neurodegenerative Disorders*

    • 8.2.1 Introduction

    • 8.2.2 Market Size Analysis and Y-o-Y Growth Analysis (%)

    • 8.2.3 Alzheimer’s Disease

    • 8.2.4 Parkinson’s Disease

    • 8.2.5 Multiple Sclerosis

    • 8.2.6 Huntington’s Disease

    • 8.2.7 Others

  • 8.3 Mental Health Disorders

    • 8.3.1 Depression

    • 8.3.2 Anxiety

    • 8.3.3 Post-Traumatic Stress Disorder

    • 8.3.4 Bipolar Disorder

    • 8.3.5 Obsessive-Compulsive Disorder (OCD)

    • 8.3.6 Others

  • 8.4 Stroke & Cerebrovascular Disorders

  • 8.5 Sleep Disorders

    • 8.5.1 Insomnia

    • 8.5.2 Sleep Apnea

    • 8.5.3 Others

  • 8.6 Cognitive Disorders

  • 8.7 Others

• 9 Digital Therapeutics for Neurological Disorders Market, By End-User

  • 9.1 Introduction

    • 9.1.1 Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

    • 9.1.2 Market Attractiveness Index, By End-User

  • 9.2 Hospitals*

    • 9.2.1 Introduction

    • 9.2.2 Market Size Analysis and Y-o-Y Growth Analysis (%)

  • 9.3 Specialty Clinics

  • 9.4 Neuro-Rehabilitation Centers

  • 9.5 Homecare Settings

  • 9.6 Others

• 10 Digital Therapeutics for Neurological Disorders Market, By Regional Market Analysis and Growth Opportunities

• 11 Introduction

  • 11.1 Market Size Analysis and Y-o-Y Growth Analysis (%), By Region

    • 11.1.1 Market Attractiveness Index, By Region

  • 11.2 North America

    • 11.2.1 Introduction

    • 11.2.2 Key Region-Specific Dynamics

    • 11.2.3 Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type

    • 11.2.4 Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type

    • 11.2.5 Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

    • 11.2.6 Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

      • 11.2.6.1 U.S
      • 11.2.6.2 Canada

  • 11.3 Europe

    • 11.3.1 Introduction

    • 11.3.2 Key Region-Specific Dynamics

    • 11.3.3 Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type

    • 11.3.4 Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type

    • 11.3.5 Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

    • 11.3.6 Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

      • 11.3.6.1 Germany
      • 11.3.6.2 U.K
      • 11.3.6.3 France
      • 11.3.6.4 Spain
      • 11.3.6.5 Italy
      • 11.3.6.6 Rest of Europe

  • 11.4 Latin America

    • 11.4.1 Introduction

    • 11.4.2 Key Region-Specific Dynamics

    • 11.4.3 Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type

    • 11.4.4 Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type

    • 11.4.5 Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

    • 11.4.6 Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

      • 11.4.6.1 Mexico
      • 11.4.6.2 Brazil
      • 11.4.6.3 Argentina
      • 11.4.6.4 Rest of Latin America

  • 11.5 Asia-Pacific

    • 11.5.1 Introduction

    • 11.5.2 Key Region-Specific Dynamics

    • 11.5.3 Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type

    • 11.5.4 Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type

    • 11.5.5 Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

    • 11.5.6 Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

      • 11.5.6.1 China
      • 11.5.6.2 India
      • 11.5.6.3 Japan
      • 11.5.6.4 South Korea
      • 11.5.6.5 Rest of Asia-Pacific

  • 11.6 Middle East and Africa

    • 11.6.1 Introduction

    • 11.6.2 Key Region-Specific Dynamics

    • 11.6.3 Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type

    • 11.6.4 Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type

    • 11.6.5 Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

• 12 Competitive Landscape and Market Positioning

• 13 Competitive Overview and Key Market Players

  • 13.1 Market Share Analysis and Positioning Matrix

  • 13.2 Strategic Partnerships, Mergers & Acquisitions

  • 13.3 Key Developments in Product Portfolios and Innovations

  • 13.4 Company Benchmarking

• 14 Company Profiles

  • 14.1 Akili, Inc.*

    • 14.1.1 Company Overview

    • 14.1.2 Product Portfolio

      • 14.1.2.1 Product Description
      • 14.1.2.2 Product Key Performance Indicators (KPIs)
      • 14.1.2.3 Historic and Forecasted Product Sales
      • 14.1.2.4 Product Sales Volume

• 15 Financial Overview

  • 15.1 Company Revenue’s

    • 15.1.1 Geographical Revenue Shares

      • 15.1.1.1 Revenue Forecasts

    • 15.1.2 Key Developments

      • 15.1.2.1 Mergers & Acquisitions
      • 15.1.2.2 Key Product Development Activities
      • 15.1.2.3 Regulatory Approvals, etc

    • 15.1.3 SWOT Analysis

  • 15.2 Click Therapeutics, Inc

  • 15.3 BigHealth

  • 15.4 Apple Inc

  • 15.5 MindMaze Inc

  • 15.6 NeuroPace, Inc

  • 15.7 NeurologyToolKit

  • 15.8 Matoph Labs e.U

  • 15.9 Fullpower Technologies, Inc

  • 15.10 Neybox Digital Ltd.LIST NOT EXHAUSTIVE

• 16 Assumption and Research Methodology

  • 16.1 Data Collection Methods

  • 16.2 Data Triangulation

  • 16.3 Forecasting Techniques

  • 16.4 Data Verification and Validation

• 17 Appendix

  • 17.1 About Us and Services

  • 17.2 Contact Us